Fluorine in PDB 6bfw: Bace Crystal Structure with Hydroxy Morpholine Inhibitor
Enzymatic activity of Bace Crystal Structure with Hydroxy Morpholine Inhibitor
All present enzymatic activity of Bace Crystal Structure with Hydroxy Morpholine Inhibitor:
3.4.23.46;
Protein crystallography data
The structure of Bace Crystal Structure with Hydroxy Morpholine Inhibitor, PDB code: 6bfw
was solved by
D.E.Timm,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
21.59 /
1.84
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
54.300,
86.130,
109.420,
90.00,
100.95,
90.00
|
R / Rfree (%)
|
18.4 /
20.6
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Bace Crystal Structure with Hydroxy Morpholine Inhibitor
(pdb code 6bfw). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Bace Crystal Structure with Hydroxy Morpholine Inhibitor, PDB code: 6bfw:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 6bfw
Go back to
Fluorine Binding Sites List in 6bfw
Fluorine binding site 1 out
of 4 in the Bace Crystal Structure with Hydroxy Morpholine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Bace Crystal Structure with Hydroxy Morpholine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:22.1
occ:1.00
|
F4
|
A:DK7401
|
0.0
|
22.1
|
1.0
|
C3
|
A:DK7401
|
1.3
|
20.1
|
1.0
|
C2
|
A:DK7401
|
2.3
|
16.3
|
1.0
|
C5
|
A:DK7401
|
2.4
|
19.5
|
1.0
|
CD1
|
A:PHE108
|
3.2
|
16.9
|
1.0
|
CA
|
A:GLY74
|
3.5
|
20.6
|
1.0
|
O
|
A:HOH609
|
3.5
|
23.0
|
1.0
|
C1
|
A:DK7401
|
3.6
|
15.6
|
1.0
|
C6
|
A:DK7401
|
3.6
|
20.5
|
1.0
|
CD2
|
A:TYR71
|
3.7
|
14.8
|
1.0
|
CA
|
A:PHE108
|
3.9
|
12.9
|
1.0
|
N
|
A:GLY74
|
3.9
|
22.3
|
1.0
|
CB
|
A:TYR71
|
3.9
|
13.6
|
1.0
|
CE1
|
A:PHE108
|
4.0
|
17.8
|
1.0
|
CG
|
A:TYR71
|
4.0
|
14.0
|
1.0
|
C
|
A:GLY74
|
4.0
|
20.4
|
1.0
|
O
|
A:LYS107
|
4.0
|
18.7
|
1.0
|
O
|
A:HOH605
|
4.1
|
26.2
|
1.0
|
C8
|
A:DK7401
|
4.1
|
17.5
|
1.0
|
CG
|
A:PHE108
|
4.2
|
13.9
|
1.0
|
O
|
A:PHE108
|
4.2
|
17.6
|
1.0
|
O
|
A:HOH891
|
4.3
|
35.5
|
1.0
|
CB
|
A:PHE108
|
4.3
|
13.3
|
1.0
|
O
|
A:GLY74
|
4.3
|
19.0
|
1.0
|
O34
|
A:DK7401
|
4.4
|
16.0
|
1.0
|
CE2
|
A:TYR71
|
4.4
|
15.3
|
1.0
|
C
|
A:PHE108
|
4.5
|
16.8
|
1.0
|
N
|
A:LYS75
|
4.6
|
15.8
|
1.0
|
F7
|
A:DK7401
|
4.7
|
20.0
|
1.0
|
N
|
A:PHE108
|
4.8
|
14.0
|
1.0
|
C
|
A:LYS107
|
4.8
|
19.1
|
1.0
|
C9
|
A:DK7401
|
4.8
|
10.3
|
1.0
|
CD1
|
A:TYR71
|
4.9
|
14.4
|
1.0
|
C32
|
A:DK7401
|
4.9
|
14.7
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 6bfw
Go back to
Fluorine Binding Sites List in 6bfw
Fluorine binding site 2 out
of 4 in the Bace Crystal Structure with Hydroxy Morpholine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Bace Crystal Structure with Hydroxy Morpholine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:20.0
occ:1.00
|
F7
|
A:DK7401
|
0.0
|
20.0
|
1.0
|
C6
|
A:DK7401
|
1.4
|
20.5
|
1.0
|
C5
|
A:DK7401
|
2.4
|
19.5
|
1.0
|
C8
|
A:DK7401
|
2.4
|
17.5
|
1.0
|
CZ2
|
A:TRP115
|
3.4
|
17.0
|
1.0
|
O
|
A:HOH817
|
3.4
|
26.2
|
1.0
|
CD1
|
A:ILE110
|
3.4
|
20.9
|
1.0
|
C3
|
A:DK7401
|
3.6
|
20.1
|
1.0
|
C1
|
A:DK7401
|
3.6
|
15.6
|
1.0
|
O
|
A:HOH752
|
3.8
|
35.5
|
1.0
|
CH2
|
A:TRP115
|
3.8
|
17.8
|
1.0
|
O
|
A:HOH779
|
4.1
|
36.7
|
1.0
|
C2
|
A:DK7401
|
4.1
|
16.3
|
1.0
|
CD2
|
A:LEU30
|
4.2
|
21.9
|
1.0
|
O
|
A:HOH605
|
4.3
|
26.2
|
1.0
|
CG1
|
A:ILE110
|
4.4
|
20.4
|
1.0
|
CE2
|
A:TRP115
|
4.5
|
17.9
|
1.0
|
O
|
A:GLN12
|
4.5
|
21.8
|
1.0
|
O
|
A:PHE108
|
4.6
|
17.6
|
1.0
|
F4
|
A:DK7401
|
4.7
|
22.1
|
1.0
|
CD1
|
A:LEU30
|
4.8
|
18.2
|
1.0
|
O
|
A:GLY230
|
4.8
|
12.2
|
1.0
|
C9
|
A:DK7401
|
4.9
|
10.3
|
1.0
|
O
|
A:HOH891
|
4.9
|
35.5
|
1.0
|
NE1
|
A:TRP115
|
5.0
|
16.1
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 6bfw
Go back to
Fluorine Binding Sites List in 6bfw
Fluorine binding site 3 out
of 4 in the Bace Crystal Structure with Hydroxy Morpholine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Bace Crystal Structure with Hydroxy Morpholine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:24.0
occ:1.00
|
F4
|
B:DK7401
|
0.0
|
24.0
|
1.0
|
C3
|
B:DK7401
|
1.3
|
20.9
|
1.0
|
C2
|
B:DK7401
|
2.3
|
18.4
|
1.0
|
C5
|
B:DK7401
|
2.3
|
20.9
|
1.0
|
CD1
|
B:PHE108
|
3.2
|
22.9
|
1.0
|
O
|
B:HOH562
|
3.4
|
22.1
|
1.0
|
CA
|
B:GLY74
|
3.5
|
21.8
|
1.0
|
C6
|
B:DK7401
|
3.6
|
21.3
|
1.0
|
C1
|
B:DK7401
|
3.6
|
17.5
|
1.0
|
CD2
|
B:TYR71
|
3.8
|
17.2
|
1.0
|
CA
|
B:PHE108
|
3.9
|
18.9
|
1.0
|
CE1
|
B:PHE108
|
3.9
|
24.1
|
1.0
|
N
|
B:GLY74
|
3.9
|
22.8
|
1.0
|
C
|
B:GLY74
|
4.0
|
22.4
|
1.0
|
O
|
B:HOH588
|
4.0
|
28.6
|
1.0
|
CB
|
B:TYR71
|
4.0
|
16.0
|
1.0
|
O
|
B:LYS107
|
4.0
|
23.7
|
1.0
|
CG
|
B:TYR71
|
4.1
|
17.1
|
1.0
|
C8
|
B:DK7401
|
4.1
|
16.8
|
1.0
|
CG
|
B:PHE108
|
4.1
|
20.0
|
1.0
|
CB
|
B:PHE108
|
4.3
|
19.5
|
1.0
|
O
|
B:PHE108
|
4.3
|
23.9
|
1.0
|
O
|
B:GLY74
|
4.3
|
21.3
|
1.0
|
O34
|
B:DK7401
|
4.4
|
19.3
|
1.0
|
O
|
B:HOH883
|
4.4
|
34.6
|
1.0
|
CE2
|
B:TYR71
|
4.5
|
18.0
|
1.0
|
N
|
B:LYS75
|
4.5
|
17.9
|
1.0
|
C
|
B:PHE108
|
4.6
|
23.5
|
1.0
|
F7
|
B:DK7401
|
4.7
|
22.2
|
1.0
|
N
|
B:PHE108
|
4.8
|
20.7
|
1.0
|
C
|
B:LYS107
|
4.8
|
24.2
|
1.0
|
C9
|
B:DK7401
|
4.9
|
14.1
|
1.0
|
C32
|
B:DK7401
|
4.9
|
17.3
|
1.0
|
CD1
|
B:TYR71
|
4.9
|
18.3
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 6bfw
Go back to
Fluorine Binding Sites List in 6bfw
Fluorine binding site 4 out
of 4 in the Bace Crystal Structure with Hydroxy Morpholine Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Bace Crystal Structure with Hydroxy Morpholine Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F401
b:22.2
occ:1.00
|
F7
|
B:DK7401
|
0.0
|
22.2
|
1.0
|
C6
|
B:DK7401
|
1.3
|
21.3
|
1.0
|
C8
|
B:DK7401
|
2.4
|
16.8
|
1.0
|
C5
|
B:DK7401
|
2.4
|
20.9
|
1.0
|
CZ2
|
B:TRP115
|
3.4
|
19.9
|
1.0
|
O
|
B:HOH815
|
3.4
|
26.7
|
1.0
|
CD1
|
B:ILE110
|
3.5
|
25.6
|
1.0
|
C3
|
B:DK7401
|
3.6
|
20.9
|
1.0
|
C1
|
B:DK7401
|
3.6
|
17.5
|
1.0
|
O
|
B:HOH802
|
3.6
|
47.5
|
1.0
|
CH2
|
B:TRP115
|
3.8
|
20.0
|
1.0
|
CD2
|
B:LEU30
|
3.9
|
26.4
|
1.0
|
C2
|
B:DK7401
|
4.1
|
18.4
|
1.0
|
O
|
B:HOH588
|
4.2
|
28.6
|
1.0
|
O
|
B:GLN12
|
4.4
|
22.1
|
1.0
|
CG1
|
B:ILE110
|
4.4
|
27.2
|
1.0
|
CE2
|
B:TRP115
|
4.5
|
20.5
|
1.0
|
O
|
B:PHE108
|
4.7
|
23.9
|
1.0
|
F4
|
B:DK7401
|
4.7
|
24.0
|
1.0
|
O
|
B:GLY230
|
4.8
|
13.7
|
1.0
|
C9
|
B:DK7401
|
4.8
|
14.1
|
1.0
|
NE1
|
B:TRP115
|
5.0
|
18.2
|
1.0
|
|
Reference:
A.B.Bueno,
J.Agejas,
H.Broughton,
R.Dally,
T.B.Durham,
J.F.Espinosa,
R.Gonzalez,
P.J.Hahn,
A.Marcos,
R.Rodriguez,
G.Sanz,
J.F.Soriano,
D.Timm,
P.Vidal,
H.C.Yang,
J.R.Mccarthy.
Optimization of Hydroxyethylamine Transition State Isosteres As Aspartic Protease Inhibitors By Exploiting Conformational Preferences. J. Med. Chem. V. 60 9807 2017.
ISSN: ISSN 1520-4804
PubMed: 29088532
DOI: 10.1021/ACS.JMEDCHEM.7B01304
Page generated: Thu Aug 1 18:07:13 2024
|